Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts

Stem Cells

Volumn 26, Issue 4, 2008, Pages 1083-1093

  Grauss, Robert W ^a   Van Tuyn, John ^a   Steendijk, Paul ^a   Winter, Elizabeth M ^a   Pijnappels, Daniël A ^a   Hogers, Bianca ^a   Gittenberger De Groot, Adriana C ^a   Van Der Geest, Rob ^a   Van Der Laarse, Arnold ^a   De Vries, Antoine A F ^a   Schalij, Martin J ^a   Atsma, Douwe E ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cellular therapy; Mesenchymal stem cells; NOD scid mouse; Transgene expression

Indexed keywords

GREEN FLUORESCENT PROTEIN; MYOCARDIN; NUCLEAR PROTEIN; TRANSACTIVATOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE VOLUME; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE REMODELING; HUMAN; HUMAN CELL; MESENCHYME CELL; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRESSURE VOLUME CURVE; PROTEIN EXPRESSION; SCID MOUSE; STEM CELL TRANSPLANTATION; ADULT; ANIMAL; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; METHODOLOGY; MOUSE MUTANT; PHENOTYPE; PHYSIOLOGY;

MUS;

ADULT; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE; MICE, INBRED NOD; MICE, SCID; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; NUCLEAR PROTEINS; PHENOTYPE; TRANS-ACTIVATORS;

EID: 49249101551     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2007-0523     Document Type: Article

References (34)

1. Schächinger V, Erbs S, Elsasser A et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006;355:1210-1221.
2. Beeres SL, Bax JJ, Dibbets-Schneider P et al. Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: Twelve-month follow-up results. Am Heart J 2006;152:684-686.
3. Tomita S, Li RK, Weisel RD et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 1999;100:247-256.
4. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res 2004;95:9-20.
5. Tang YL, Zhao Q, Qin X et al. Paracrine action enhances the effects of autologous mesenchymal stem cell transplantation on vascular regeneration in rat model of myocardial infarction. Ann Thorac Surg 2005;80:229-236.
6. Dai W, Hale SL, Martin BJ et al. Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: Short- and long-term effects. Circulation 2005;112:214-223.
7. Silva GV, Litovsky S, Assad JA et al. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 2005;111:150-156.
8. Nagaya N, Kangawa K, Itoh T et al. Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy. Circulation 2005;112:1128-1135.
9. Xu W, Zhang X, Qian H et al. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp Biol Med 2004;229:623-631.
10. Murry CE, Soonpaa MH, Reinecke H et al. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 2004;428:664-668.
11. Nakamura Y, Wang XH, Xu CS et al. Xenotransplantation of long-term-cultured swine bone marrow-derived mesenchymal stem cells. STEM CELLS 2007;25:612-620.
12. Chien KR. Stem cells: Lost in translation. Nature 2004;428:607-608.
13. Bartunek J, Croissant JD, Wijns W et al. Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium. Am J Physiol Heart Circ Physiol 2007;292:H1095-H1104.
14. Li TS, Hayashi M, Ito H et al. Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta- preprogrammed bone marrow stem cells. Circulation 2005;111:2438-2445.
15. Wang DZ, Chang PS, Wang ZG et al. Activation of cardiac gene expression by myocardin, a transcriptional cofactor for serum response factor. Cell 2001;105:851-862.
16. Miano JM. Serum response factor: Toggling between disparate programs of gene expression. J Mol Cell Cardiol 2003;35:577-593.
17. van Tuyn J, Knaan-Shanzer S, van de Watering MJ et al. Activation of cardiac and smooth muscle-specific genes in primary human cells after forced expression of human myocardin. Cardiovasc Res 2005;67:245-255.
18. van Tuyn J, Pijnappels DA, de Vries AA et al. Fibroblasts from human postmyocardial infarction scars acquire properties of cardiomyocytes after transduction with a recombinant myocardin gene. FASEB J 2007;21:3369-3379.
19. Grauss RW, Winter EM, van Tuyn et al. Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction. Am J Physiol Heart Circ Physiol 2007;293:H2438-H2447.
20. Bal MP, De Vries WB, Van der Leij FR et al. Neonatal glucocorticosteroid treatment causes systolic dysfunction and compensatory dilatation in early life: Studies in 4-week-old prepubertal rats. Pediat Res 2005;58:46-52.
21. Shake JG, Gruber PJ, Baumgartner WA et al. Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects. Ann Thorac Surg 2002;73:1919-1925.
22. Chen SL, Fang WW, Ye F et al. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. Am J Cardiol 2004;94:92-95.
23. Nygren JM, Jovinge S, Breitbach M et al. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat Med 2004;10:494-501.
24. Tang YL, Tang Y, Zhang YC et al. Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 2005;46:1339-1350.
25. Mangi AA, Noiseux N, Kong DL et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9:1195-1201.
26. Jiang SJ, Haider HK, Idris NM et al. Supportive interaction between cell survival signaling and angiocompetent factors enhances donor cell survival and promotes angiomyogenesis for cardiac repair. Circ Res 2006;99:776-784.
27. Yang Z, Berr SS, Gilson WD et al. Simultaneous evaluation of infarct size and cardiac function in intact mice by contrast-enhanced cardiac magnetic resonance imaging reveals contractile dysfunction in noninfarcted regions early after myocardial infarction. Circulation 2004;109:1161-1167.
28. Anker SD, Sharma R. The syndrome of cardiac cachexia. Int J Cardiol 2002;85:51-66.
29. Murphy AM. Contractile protein phenotypic variation during development. Cardiovasc Res 1996;31:E25-E33.
30. Chuva de Sousa Lopes SM, Hassink RJ, Feijen A et al. Patterning the heart, a template for human cardiomyocyte development. Dev Dyn 2006;235:1994-2002.
31. Hailstones D, Barton P, Chan-Thomas P et al. Differential regulation of the atrial isoforms of the myosin light chains during striated muscle development. J Biol Chem 1992;267:23295-23300.
32. Madonna R, Willerson JT, Geng YJ. Myocardin A enhances telomerase activities in adipose tissue mesenchymal cells and embryonic stem cells undergoing cardiovascular myogenic differentiation. STEM CELLS 2008;26:202-211.
33. Berry MF, Engler AJ, Woo YJ et al. Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance. Am J Physiol Heart Circ Physiol 2006;290:H2196-H2203.
34. Kinnaird T, Stabile E, Burnett MS et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004;109:1543-1549.